These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 24796622)
41. Alpha-carboxyamidation of antral progastrin. Relation to other post-translational modifications. Hilsted L; Rehfeld JF J Biol Chem; 1987 Dec; 262(35):16953-7. PubMed ID: 3680281 [TBL] [Abstract][Full Text] [Related]
42. Randomised trial of the effect of a gastrin/CCK Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466 [TBL] [Abstract][Full Text] [Related]
43. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients. Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963 [TBL] [Abstract][Full Text] [Related]
44. Processing of the gastrin precursor. Modulation of phosphorylated, sulfated, and amidated products. Varro A; Nemeth J; Bridson J; Lee C; Moore S; Dockray GJ J Biol Chem; 1990 Dec; 265(35):21476-81. PubMed ID: 1701434 [TBL] [Abstract][Full Text] [Related]
45. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728 [TBL] [Abstract][Full Text] [Related]
48. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors]. Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832 [TBL] [Abstract][Full Text] [Related]
49. Diagnostic accuracy of selective arterial calcium injection test for localization of gastrinoma. Hayashi R; Minami I; Sasahara Y; Izumiyama H; Yoshimoto T; Kishino M; Kudo A; Tateishi U; Tanabe M; Yamada T Endocr J; 2020 Mar; 67(3):305-315. PubMed ID: 31813923 [TBL] [Abstract][Full Text] [Related]
50. Excretion of progastrin products in human urine. Hansen CP; Goetze JP; Stadil F; Rehfeld JF Am J Physiol; 1999 Apr; 276(4):G985-92. PubMed ID: 10198343 [TBL] [Abstract][Full Text] [Related]
51. Identification of gastrin component I as gastrin-71. The largest possible bioactive progastrin product. Rehfeld JF; Johnsen AH Eur J Biochem; 1994 Aug; 223(3):765-73. PubMed ID: 8055952 [TBL] [Abstract][Full Text] [Related]
52. [Quick radioimmunoassay for plasma immunoreactive gastrin--application for localizing occult gastrinoma(s) during operation]. Sasakuma F; Shimizu T; Ishikawa O; Taku K; Doi K; Kojima J Rinsho Byori; 1996 May; 44(5):471-6. PubMed ID: 8676568 [TBL] [Abstract][Full Text] [Related]
53. Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues. Del Valle J; Sugano K; Yamada T Gastroenterology; 1987 Jun; 92(6):1908-12. PubMed ID: 3569767 [TBL] [Abstract][Full Text] [Related]
54. Ovarian cancers express and process progastrin. van Solinge WW; Odum L; Rehfeld JF Cancer Res; 1993 Apr; 53(8):1823-8. PubMed ID: 8467501 [TBL] [Abstract][Full Text] [Related]
55. Effect of proton-pump inhibitor therapy on serum chromogranin a level. Pregun I; Herszényi L; Juhász M; Miheller P; Hritz I; Patócs A; Rácz K; Tulassay Z Digestion; 2011; 84(1):22-8. PubMed ID: 21304238 [TBL] [Abstract][Full Text] [Related]